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1 Authors made equal contribution.While the prion protein (PrP) is clearly involved in neuropathology, its physiological roles remain
elusive. Here, we demonstrate PrP functions in cell–substrate interaction in Drosophila S2, N2a
and HeLa cells. PrP promotes cell spreading and/or ﬁlopodia formation when overexpressed, and
lamellipodia when downregulated. Moreover, PrP normally accumulates in focal adhesions (FAs),
and its downregulation leads to reduced FA numbers, increased FA length, along with Src and focal
adhesion kinase (FAK) activation. Furthermore, its overexpression elicits the formation of novel
FA-like structures, which require intact reggie/ﬂotillin microdomains. Altogether, PrP modulates
process formation and FA dynamics, possibly via signal transduction involving FAK and Src.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction uncover new roles of PrP in cell spreading and process extension.The physiological role of the cellular prion protein (PrPC, hence-
forth called ‘‘PrP”) remains poorly understood. However, it is
thought to play roles in neuroprotection, cell adhesion and signal
transduction [1,2]. Our previous results using T cells have revealed
that PrP can induce signal transduction in association with reggie/
ﬂotillin microdomains [3], which are thought to serve as platforms
for the assembly of multiprotein signalling complexes [4]. For in-
stance, reggies are known to interact with Src tyrosine kinases
[5], the adaptor proteins CAP and vinexin [6], and actin [7]. In addi-
tion, we recently showed that reggies are required for the recruit-
ment of CAP to focal adhesions (FAs) [8] and the regulation of cell
morphology [8,9].
Given the close association of PrP and reggies, we here investi-
gated possible functions of PrP in cell–substrate interaction, FA and
process formation. To this aim, Drosophila S2, mouse N2a and
human HeLa cells were used to study the effect of PrP overexpres-
sion and downregulation on cell–substrate interaction. Our resultschemical Societies. Published by E
n; FAK, focal adhesion kinase;
oscopy; R1EA, reggie-1 EA
P. Solis).
de (G.P. Solis), Claudia.Remarkably, PrP modulates FA dynamics and the formation of
FA-like structures, which seem to depend on reggie.
2. Materials and methods
2.1. Reagents and antibodies
Cell culture reagents were purchased from Gibco BRL (Ger-
many). Antibody information is provided under Supplementary
material.
2.2. Plasmids
The cloning procedures for the PrP, EGFP-PrP, EGFP-GPI, DsRed-
PrP, and ECFP-R1EA constructs are described in Supplementary
material. The rat reggie-1-HA construct has been described
previously [10]. The GFP-paxillin and b3-integrin-GFP vectors were
kindly provided by Yamada and Imhof, respectively.
2.3. Cell culture, transfection, and siRNA
N2a and HeLa cells were cultured in MEM supplemented
with 10% FCS, L-glutamine, pyruvate and penicillin/streptomycin,
and transfected using Lipofectamine 2000 (Invitrogen). S2 cells
cultured in Schneider’s Medium supplemented with 10% FCS,lsevier B.V. All rights reserved.
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Effectene (Qiagen). Duplexed small interfering RNAs (siRNAs) were
transfected at 100 pmol/ml. The target sequences for mouse and
human PrPs were: 5-CTGATTGAAGGCAACAGGAAA-3 and 5-CAG-
CAAATAACCATTGGTTAA-3, respectively (Qiagen). siRNA against
ﬁreﬂy luciferase (GL2, Dharmacon) served as control.
2.4. Spreading assay
S2 cells were transfected for 24 h, seeded on coverslips coated
with alcian blue, poly-lysine, laminin or ﬁbronectin (Sigma–Al-
drich) for 1 h, and stained with phalloidin. Cell area (excluding
ﬁlopodia) was scored from 20 randomly selected ﬁelds (>80 cells).
2.5. Fluorescence, ﬁlopodia and FA quantiﬁcation
N2a cells were transfected for 24–48 h, seeded on poly-lysine
coated coverslips for 24 h, and stained with anti-GFP or anti-PrP
antibodies (non-permeabilizing conditions), or with phalloidin or
anti-paxillin antibody (permeabilizing conditions). The membrane
expression levels of our constructs were controlled by measuring
anti-GFP indirect ﬂuorescence (50 cells/construct). Filopodial
length was scored in two independent experiments (50 single
cells). FA number and length were scored in four independent
experiments (>200 cells).
2.6. Microscopy
N2a, HeLa and S2 cells were immunostained as previously de-
scribed [7], and visualized using a Plan-Apochromat 63/1.4 objec-
tive in a confocal microscope (LSM510 META) and/or Axioplan2
equipped with an AxioCam HRm (wideﬁeld images). For total
internal reﬂection ﬂuorescence microscopy (TIRFM), the TIRF slider
system and a a-Plan Fluar 100/1.45 objective were used with an
Axiovert 200M (all Zeiss). Images were processed using the Axiovi-
sion 4.6 or LSM510 softwares (Zeiss).
2.7. Immunoblotting
N2a cells were lysed using ice-cold lysis buffer (20 mM Tris–HCl
pH 7.5, 100 mM NaCl, 5 mM MgCl2, 2 mM EDTA, 1% Triton X-100,Fig. 1. PrP induces spreading and ﬁlopodia formation in S2 cells. (A) Transfected S2 cells
(green) and phalloidin to visualize F-actin (red). Confocal images of a cell expressing no
transfected cells (arrowheads). Scale bar: 5 lm. (B) Quantiﬁcation of the area shows that
poly-lysine, laminin or ﬁbronectin coated coverslips. Non-transfected (Control) and tra
shown are the mean ± S.D. *P < 0.05, One-Way ANOVA.10% Glycerin) supplemented with protease and phosphatase inhib-
itor cocktails (Calbiochem). Hundred microgram proteins were
loaded per lane and immunoblotted as previously reported
(n = 4) [8].3. Results and discussion
3.1. PrP induces cell spreading and ﬁlopodia formation
To assess if PrP affects cell–substrate interaction, we used Dro-
sophila S2 cells, a PrP-negative non-adhesive cell line routinely
used to characterize adhesion molecules. Upon transfection, PrP-
expressing cells showed remarkable spreading on alcian blue,
and produced abundant ﬁlopodia (Fig. 1A). These effects were also
observed upon expression of an EGFP-PrP fusion protein but not of
the EGFP-GPI control construct (Fig. S1). Since PrP interacts with
laminin but not ﬁbronectin [11], we performed spreading assays
on these substrates. For all substrates tested, the area covered by
cells expressing non-tagged PrP or EGFP-PrP was 4-fold larger than
that of control cells (transfected with EGFP-GPI or non-transfected;
Fig. 1B). Thus, heterologous PrP expression in S2 cells triggers cell
spreading and ﬁlopodia extension in a substrate-independent
manner.
3.2. PrP levels regulate process formation
The results obtained in S2 cells prompted us to analyze if PrP
would also affect the morphology of mammalian cells. For this,
we used mouse neuroblastoma N2a cells, a cell line frequently em-
ployed for the characterization of PrP cellular properties. Upon
expression of EGFP-PrP, the spontaneous levels of spreading in
N2a cells were not altered (data not shown). However, we ob-
served a signiﬁcant increase in the number of ﬁlopodia >10 lm
length (11.2 ± 3.3 ﬁlopodia/cell), as well as in the length of the lon-
gest ﬁlopodium (18.4 ± 2.8 lm), compared to EGFP-GPI transfected
cells (2.0 ± 1.3 ﬁlopodia/cell and 11.4 ± 2.7 lm, respectively)
(Fig. 2A–D). Interestingly, PrP often accumulated in ﬁlopodial tips
(Fig. 2A). Corresponding controls showed that both EGFP-fusion
proteins were efﬁciently expressed (Fig. S2) and equally presented
on the plasma membrane (Fig. S3A–E), and also that the endoge-were transferred to alcian blue coated coverslips, and stained with anti-PrP antibody
n-tagged PrP show increased cell area and formation of ﬁlopodia compared to non-
S2 cells expressing non-tagged PrP or EGFP-PrP spread equally well on alcian blue,
nsfected cells expressing EGFP-GPI do not spread under these conditions. Values
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(Fig. S2F and G). Thus, PrP overexpression positively inﬂuences ﬁl-
opodia formation and extension. To strengthen this observation,
we used siRNAs to knockdown PrP in N2a cells (>95% efﬁciency;
Fig. S4). Indeed, siRNA-treated cells showed signiﬁcantly fewer ﬁl-
opodia but extensive lamellipodial veils (Fig. 2E) compared to con-
trol, wild type or PrP-overexpressing cells (Fig. 2A, B and E). Rescue
experiments performed by co-transfecting siRNA and EGFP-PrP
(lacking the siRNA binding site) considerably reverted this abnor-
mal cell morphology (Fig. 2F). Altogether, these results indicate
that the surface levels of PrP expression regulate process forma-
tion: PrP absence elicits lamellipodia formation and increased PrP
levels induce ﬁlopodia formation and extension.
3.3. PrP is a component of FAs
The PrP morphological phenotypes observed in S2 and N2a
cells strongly suggested an involvement of PrP in cell–substrate
interaction. Since FAs play a pivotal role in cell–cell matrix inter-
actions, we took advantage of TIRFM to analyze the localization of
PrP at the cell–substrate interface using FA markers such as pax-
illin and vinculin. Non-transfected N2a cells grown on poly-lysine
exhibited few paxillin/PrP-positive FAs (data not shown). Notably,
overexpression of EGFP-PrP, but not EGFP-GPI, induced strong
accumulation of EGFP-PrP at discrete dotted and streak-shaped
structures (Fig. 3A and B, and Fig. S5A). While some of these
structures co-localized with paxillin, some others did not
(Fig. 3A), and were therefore termed FA-like structures. To further
analyze the presence of PrP in FAs, we immunostained human
epithelial HeLa cells, which form quite prominent FAs. In non-
transfected cells, we observed a distinct accumulation of endoge-
nous PrP at vinculin-positive FAs on poly-lysine (Fig. 3C), laminin
and ﬁbronectin (data not shown). Particularly, PrP-positive FAs
were localized at the end of stress ﬁbers (Fig. 3D, and Fig. S6G)
and exhibited additional FA markers, such as b3-integrin, pFAK,Fig. 2. PrP-dependent ﬁlopodia extension in N2a cells. (A and B) N2a cells were transfec
phalloidin (red). Wideﬁeld images of cells expressing EGFP-PrP (A), but not EGFP-GPI
magniﬁcation ﬁelds). (C and D) N2a cells, prepared as above, were used to quantify the eff
the mean ± S.E.M. **P < 0.001, Mann–Whitney Rank Sum Test. (E and F) N2a cells were tr
transferred to poly-lysine coated coverslips for 24 h, and stained with anti-PrP (green
number and length, and lamellipodia formation upon PrP downregulation (arrowheads in
EGFP-PrP co-transfection (arrowhead in F). Scale bars: 10 lm.pSrc, and reggie-1 (Fig. S6A–F). PrP accumulation in FAs was not
observed in HeLa cells treated with siRNA, conﬁrming the speci-
ﬁcity of the immunostaining (Fig. S7). Like in N2a cells, overex-
pression of EGFP-PrP, but not of EGFP-GPI, resulted in the
appearance of FA-like structures in HeLa cells (Fig. 3E and F,
and Fig. S5B), some of which partially co-localized with paxillin
(Fig. 3E). Moreover, in both cell types PrP often resided at the dis-
tal end of FAs, much like pERK in ﬁbroblasts [12], suggesting a
signalling role of PrP in these structures. Altogether, these data
indicate that PrP is a component of FA and that novel FA-like
structures are induced upon PrP overexpression.
The PrP/paxillin-positive FAs observed here appear to represent
‘‘classical” FAs. On the other hand, the paxillin-negative FA-like
structures might reﬂect different maturational states of FAs. Alter-
natively, they may constitute functionally distinct FAs, as it is
known that FAs can differ in size and protein composition [13].
Hence, PrP may be present in ‘‘exploratory” and early FA-com-
plexes with high turnover rates, and may thus play a role in the
exploratory activity of ﬁlopodial tips.
3.4. PrP regulates FA dynamics
To determine if PrP regulates characteristic FA properties, we
quantitatively analyzed paxillin-positive FAs in N2a cells. Interest-
ingly, PrP downregulation caused a signiﬁcant reduction in FA
number (30%) along with an increase in the size of the longest
FA per cell (Table 1). Moreover, while most of the siRNA-treated
N2a cells showed an increase in the number of large FAs
(>1 lm), the majority of PrP-overexpressing cells exhibited higher
numbers of small FAs (<1 lm; Table 1). These data indicate that
PrP can affect FA number and size. Because the size of FAs reﬂects
differences in their turnover rates [14], we speculated that PrP
might also regulate FA turnover. Accordingly, N2a cells over-
expressing PrP showed higher turnover rates of GFP-paxillin FAs
compared to PrP downregulated cells (Videos S1A and B).ted for 24 h, transferred to poly-lysine coated coverslips for 24 h, and stained with
(B), show long ﬁlopodia with accumulation of PrP at ﬁlopodia tips (arrowheads,
ects of PrP overexpression on ﬁlopodia number (C) and length (D). Values shown are
ansfected with siRNA against PrP (E) and co-transfected with EGFP-PrP (F) for 48 h,
in E) and phalloidin (red). Wideﬁeld images show a strong reduction of ﬁlopodia
E). siRNA-mediated effects on ﬁlopodia and lamellipodia formation are reverted by
Fig. 3. PrP resides in FAs. (A and B) N2a cells were prepared as described in Fig. 2, stained with anti-paxillin antibody (red) and visualized by TIRFM. Expression of EGFP-PrP
(A), but not EGFP-GPI (B), induces the formation of FA-like structures (red arrows). PrP localizes at distal ends of FAs (arrowheads, magniﬁcation ﬁeld in A). (C and D) Non-
transfected HeLa cells were grown on poly-lysine coated coverslips, and stained with antibodies against PrP (green) and vinculin (red in C) or phalloidin (red in D). TIRFM
images show that endogenous PrP co-localizes with vinculin in FAs (arrowheads in C). A merged wideﬁeld image shows the localization of endogenous PrP at the tips of stress
ﬁbers (arrowheads in D). (E and F) Transfected HeLa cells, prepared as N2a cells in Fig. 2, were analyzed by TIRFM. Overexpression of EGFP-PrP (E), but not of EGFP-GPI (F),
induces formation of FA-like structures (red arrows in E). Note that in HeLa cells endogenous PrP and EGFP-PrP also localize at the distal ends of FAs (arrowheads in
magniﬁcation ﬁelds in C and E). (G) Immunoblots from N2a cells transfected with EGFP empty vector (control), EGFP-PrP or siRNA against PrP (siRNA). The signals of
phosphorylated Src (pSrc Y416) and FAK (pFAK Y576/577), but not pFAK Y397, increase upon PrP downregulation. (H) N2a cells were transfected with the EGFP-PrP and
reggie-1-HA vectors, cultured as above, stained with anti-HA antibody (red) and recorded by TIRFM. PrP and reggie-1 clearly co-localize in FA-like structures (arrowheads). (I
and J) EGFP-PrP FA-like structures observed by TIRFM are lost upon co-expression of the DSRed-R1EA construct in N2a (I) and HeLa (J) cells (region with arrow is enlarged in
I). Scale bars: 10 lm.
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of focal adhesion kinase (FAK) by Src are involved in the regulation
of FA turnover [15], we examined if PrP affects the phosphorylation
states of both kinases. In fact, immunoblots using phospho-speciﬁc
antibodies revealed a signiﬁcant increase in the levels of pSrc and
pFAK Y576/577 upon PrP downregulation (Fig. 3G, and Fig. S8); the
levels of FAK autophosphorylation at Y397 were not affected. Ta-
ken together, these results indicate that PrP modulates FA dynam-
ics, possibly by regulating Src and FAK phosphorylation.
3.5. PrP-dependent FA-like structures require reggie microdomains
We have shown that reggie microdomains are involved in PrP
clustering and signalling [3], as well as in the activation of Rho-
family GTPases and the recruitment of CAP to FAs [8]. Therefore,Table 1
PrP-mediated regulation of FA number and size.
EGFP EGFP-Pr
FAs/100 lm2 1.59 ± 0.47 1.46 ± 0
% Of cells with mostly small FAs (<1 lm) 50.66 ± 0.83 67.72 ±
% Of cells with mostly large FAs (>1 lm) 49.34 ± 0.83 32.28 ±
Longest FA (lm) 2.32 ± 0.41 2.32 ± 0
Paxillin-postive FAs were analyzed from N2a cells transfected with EGFP empty vector
GL2). Cells were prepared as described in Fig. 2. Values shown are the mean ± S.E.M. *Pwe examined the contribution of reggie to the formation of PrP-
dependent FA-like structures. In N2a cells, EGFP-PrP clearly co-
localized with reggie-1 in FA-like structures (Fig. 3H). Notably, in
N2a and HeLa cells the formation of PrP FA-like structures was
completely abrogated by co-expression of a reggie-1 trans-nega-
tive construct (R1EA) (Fig. 3I and J, and Fig. S9), indicating that in-
tact reggie microdomains are necessary for this process.
Altogether, the present data is consistent with our view [4] that
PrP requires reggie microdomains for its communication with sig-
nal transduction pathways involving Src, FAK, CAP and small GTP-
ases, here regulating ﬁlopodia formation and FA dynamics.
Interestingly, we have additionally observed that PrP expression
induces S2 cell clustering, along with the concomitant accumula-
tion of PrP and reggies at contact sites (G.P. Solis, unpublished),
which suggests a role of these molecules in cell contact formation.P EGFP-GPI siRNA PrP siRNA GL2
.49 1.46 ± 0.44 1.12 ± 0.38* 1.57 ± 0.50
3.00** 48.62 ± 3.46 34.79 ± 1.97** 50.59 ± 1.08
3.00** 51.38 ± 3.46 65.21 ± 1.97** 49.12 ± 1.08
.47 2.35 ± 0.41 2.78 ± 0.48* 2.37 ± 0.46
(EGFP), EGFP-PrP, EGFP-GPI, siRNA against PrP (siRNA PrP) or control siRNA (siRNA
< 0.05, **P < 0.001 (One-Way ANOVA).
Y. Schrock et al. / FEBS Letters 583 (2009) 389–393 393Therefore, we propose that PrP is part of a multiprotein complex
centered on reggies and their signalling partners, which initiates
the formation of speciﬁc membrane domains such as the T cell
cap, cell–cell contacts and here cell–substrate contacts.
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